PF-Atlas › Research
IPF Research Library (7,017 papers)
7,017 papers indexed by PF-Atlas AI agents across PubMed, bioRxiv and global journals, organized into research topics. Core IPF science is separated from cross-disease research so relevance is explicit.
Core IPF research
Studies focused directly on idiopathic pulmonary fibrosis biology, treatment and regeneration.
- Preprints · 1331 papers
- medRxiv Dev · 332 papers
- medRxiv Seno · 290 papers
- medRxiv Gene · 106 papers
- Gene Editing · 32 papers
- In-Vivo CAR · 32 papers
- Longevity · 31 papers
- TGF-β Signaling · 28 papers
- Exosomes · 27 papers
- medRxiv IPF · 27 papers
- AI Discovery · 26 papers
- Mental Health · 25 papers
- Retina→IPF · 25 papers
- Senescence · 25 papers
- Microbiome · 24 papers
- Post-Surgery · 24 papers
- Epigenetics · 23 papers
- GEN News · 23 papers
- NIH Grants IPF · 23 papers
- mRNA Innovation · 23 papers
- PF News · 22 papers
- Surgery Risk · 22 papers
- Exacerbation · 21 papers
- STAT News · 21 papers
- Telomere Biology · 21 papers
- Epithelial Repair · 20 papers
- CRISPR Cures · 19 papers
- Organoids · 19 papers
- Senolytics · 19 papers
- Early Detection · 18 papers
- Muscle→IPF · 18 papers
- NIH Grants Dev · 18 papers
- CrossRef IPF · 17 papers
- Fibroblast Biology · 17 papers
- Germany Pharma · 17 papers
- IPF Patents · 17 papers
- Cure Research · 16 papers
- CrossRef Regen · 15 papers
- CrossRef Senolytic · 15 papers
- Cure Signal · 15 papers
- Environment · 15 papers
- LNP Patents · 15 papers
- Regen Med 2025 · 15 papers
- Rehabilitation · 15 papers
- Reversal Research · 15 papers
- Immune Aging · 14 papers
- Senolytic Patents · 14 papers
- Stem Cell EU · 14 papers
- Transplant Deep · 14 papers
- mRNA Beyond · 14 papers
- CardioIPF · 13 papers
- CrossRef Reversal · 13 papers
- MS→IPF · 13 papers
- NIH Grants Seno · 13 papers
- Russia 2025 · 13 papers
- Russia Deep · 13 papers
- Switzerland Pharma · 13 papers
- Genetic IPF · 12 papers
- Regeneration · 12 papers
- Surgery EU · 12 papers
- Caregiver · 11 papers
- CrossRef mRNA · 11 papers
- NIH Grants FGF · 11 papers
- Diabetes→IPF · 10 papers
- Organoid SS · 10 papers
- Reprogramming Patents · 10 papers
- Palliative · 9 papers
- GERD · 8 papers
- Israel · 8 papers
- Oxygen Therapy · 8 papers
- Prognosis · 8 papers
- ROCK Signaling · 8 papers
- Russia · 8 papers
- Sleep · 8 papers
- ECM Engineering · 7 papers
- Scandinavia · 7 papers
- Cell Therapy · 6 papers
- EUCTR · 6 papers
- Europe Deep · 6 papers
- Phase III 2026 · 6 papers
- Vascular · 6 papers
- Europe · 5 papers
- FDA Approved 2025 · 5 papers
- Integrin Biology · 5 papers
- Russia Novel · 5 papers
- Alzheimer→IPF · 4 papers
- Biomarkers · 4 papers
- Growth Factors · 4 papers
- Lifestyle · 4 papers
- Macrophage Biology · 4 papers
- Regression · 4 papers
- Aging=IPF · 3 papers
- CAR-T Senolytic · 3 papers
- COVID→IPF · 3 papers
- Gut-Lung Axis · 3 papers
- Light Therapy · 3 papers
- Niche Biology · 3 papers
- Reprogramming · 3 papers
- medRxiv Regen · 3 papers
- Dev Restart · 2 papers
- Epigenetic Aging · 2 papers
- Fetal→IPF · 2 papers
- FiercePharma · 2 papers
- Germany · 2 papers
- Latin America · 2 papers
- Mechanosensing · 2 papers
- NAD+ Longevity · 2 papers
- AI Diagnosis · 1 paper
- AI Target Discovery · 1 paper
- Aging→IPF · 1 paper
- Anesthesia · 1 paper
- Axolotl Biology · 1 paper
- Coagulation · 1 paper
- Dendritic Cell Biology · 1 paper
- Epigenetic Reprogramming · 1 paper
- Eye→IPF · 1 paper
- GLP-1 Anti-Fibrotic · 1 paper
- GLP-1 Multi-Organ · 1 paper
- GLP-1 Organ Protection · 1 paper
- HBOT · 1 paper
- Immune Cell Therapy · 1 paper
- Immune Memory · 1 paper
- Immune Reset · 1 paper
- In-Vivo CAR-T · 1 paper
- Iran Advanced · 1 paper
- LPA1 Antagonist · 1 paper
- Lupus→IPF · 1 paper
- Non-coding RNA · 1 paper
- PDE4B Inhibition · 1 paper
- PDGFR-alpha Dev · 1 paper
- Prostacyclin · 1 paper
- REGEND001 · 1 paper
- Reprogramming + Telomeres · 1 paper
- Retinoic Acid · 1 paper
- Senolytic CAR-T · 1 paper
- Single Cell 2025 · 1 paper
- Symptoms · 1 paper
- Transplant · 1 paper
- Tumor-Fibrosis · 1 paper
- VEGF Dev · 1 paper
- WNT Patents · 1 paper
- WNT Pathway · 1 paper
- mTOR Longevity · 1 paper
Cross-disease research
Research from oncology, liver and cardiac fibrosis, aging and regenerative medicine that may have mechanistic relevance to pulmonary fibrosis — tracked deliberately, not mistaken for IPF-specific evidence.
- Heart Crossover · 48 papers
- Cancer Crossover · 46 papers
- Liver Crossover · 46 papers
- Cardiac-Pulmonary · 23 papers
- Heart Failure · 23 papers
- Skin Crossover · 23 papers
- Kidney Crossover · 20 papers
- Cardiac+Lung · 17 papers
- CAR-T Non-Cancer · 13 papers
- Heart+ILD · 12 papers
- Cancer Cross · 8 papers
- Liver→IPF · 5 papers
- Cardiac Risk · 4 papers
- Cancer Immuno→IPF · 3 papers
Regional & language research
IPF research grouped by region and language to surface findings outside English-language journals.
- Russian Language · 2987 papers
- China · 54 papers
- Korean Language · 43 papers
- Asia Deep · 21 papers
- Australia · 20 papers
- China TCM · 18 papers
- Chinese Language · 17 papers
- Japan ROCK 2025 · 17 papers
- Japanese Language · 17 papers
- China TCM 2025 · 16 papers
- Global 2024 · 16 papers
- Senolytics Global · 16 papers
- Japan · 15 papers
- China Deep · 14 papers
- Japan Deep · 13 papers
- China LNP · 9 papers
- India · 9 papers
- Korea · 7 papers
- China Combo · 6 papers
- Japan iPSC · 3 papers
Note. Cross-disease papers are included for mechanistic context. They are not evidence for treating IPF and are labeled separately for that reason.